Orphan drugs in Europe

被引：0
|
作者：
Emma Dorey
机构：
来源：
Nature Biotechnology | 1999年 / 17卷 / 8期
关键词：
D O I：
10.1038/11639
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：737 / 737
相关论文
共 50 条
  • [31] THE ORPHAN DRUGS
    KASILO, O
    FIORICA, E
    REGGI, V
    TOGNONI, G
    MEDICINA-RIVISTA DELLA ENCICLOPEDIA MEDICA ITALIANA, 1986, 6 (03): : 295 - 300
  • [32] ORPHAN DRUGS
    RHEIN, R
    BRITISH MEDICAL JOURNAL, 1990, 301 (6745): : 198 - 199
  • [33] Orphan drugs
    Novack, Gary D.
    OCULAR SURFACE, 2008, 6 (01): : 52 - 55
  • [34] ORPHAN DRUGS
    不详
    SOUTH AFRICAN MEDICAL JOURNAL, 1983, 63 (24): : 914 - 914
  • [35] ORPHAN DRUGS
    Fontanet Sacristan, Juan Manuel
    Torrent-Farnell, Josep
    ARBOR-CIENCIA PENSAMIENTO Y CULTURA, 2018, 194 (789)
  • [36] Orphan drugs and orphan tests in the USA
    Thoene, JG
    COMMUNITY GENETICS, 2004, 7 (04) : 169 - 172
  • [37] THE RISE OF ORPHAN DRUGS IN EUROPE VS THE UNITED STATES: COMPARING ORPHAN DRUG DESIGNATIONS BETWEEN THE EMA AND FDA
    Mildred, M.
    Lee, S.
    VALUE IN HEALTH, 2015, 18 (07) : A677 - A677
  • [38] The quality of economic evaluations of ultra-orphan drugs in Europe - a systematic review
    Schuller, Y.
    Hollak, C. E. M.
    Biegstraaten, M.
    ORPHANET JOURNAL OF RARE DISEASES, 2015, 10
  • [39] The quality of economic evaluations of ultra-orphan drugs in Europe – a systematic review
    Y. Schuller
    C. E. M. Hollak
    M. Biegstraaten
    Orphanet Journal of Rare Diseases, 10
  • [40] Involvement of Patient Organisations in Research and Development of Orphan Drugs for Rare Diseases in Europe
    Mavris, M.
    Le Cam, Y.
    MOLECULAR SYNDROMOLOGY, 2012, 3 (05) : 237 - 243
12345